Skip to main content
. 2023 Nov 3;15(21):5283. doi: 10.3390/cancers15215283

Table 7.

Antitumor activity (EC50, μM) of selected compounds.

MV4;11 Molm13 NB4 HL60 Hela
2 33 ± 2.8 29 ± 2.5 32 ± 2.0 50 >50
12 26 ± 1.8 50 50 50 >50
15 22 ± 2.0 10 ± 1.6 >50 50 >50
24 9.6 ± 1.2 4.7 ± 0.3 5.3 ± 1.1 10 ± 1.8 50
25 8.7 ± 0.9 9.4 ± 0.8 10 ± 0.5 26 ± 2.6 50
50 8.2 ± 1.2 5.1 ± 0.2 9.4 ± 1.2 9.0 ± 0.9 25 ± 2.5
57 21 ± 1.2 13 ± 1.7 11 ± 0.4 9.7 ± 1.2 50
22 >50 >50 >50 >50 >50
37 >50 >50 >50 >50 >50
72 ~50 >50 >50 >50 >50